Credit Suisse’s Ironwood Pharmaceuticals IRWD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | $1.72M | Sell |
197,789
-5,414,324
| -96% | -$65.7M | ﹤0.01% | 1959 |
|
|
2023
Q4 | $64.2M | Buy |
5,612,113
+1,110,544
| +25% | +$11M | 0.06% | 314 |
|
|
2023
Q3 | $43.4M | Sell |
4,501,569
-1,298,944
| -22% | -$12.7M | 0.04% | 423 |
|
|
2023
Q2 | $61.7M | Buy |
5,800,513
+628,844
| +12% | +$6.76M | 0.06% | 330 |
|
|
2023
Q1 | $54.4M | Sell |
5,171,669
-29,034
| -0.6% | -$325K | 0.05% | 372 |
|
|
2022
Q4 | $64.4M | Buy |
5,200,703
+557,798
| +12% | +$6.33M | 0.07% | 307 |
|
|
2022
Q3 | $48.1M | Buy |
4,642,905
+221,377
| +5% | +$2.51M | 0.05% | 385 |
|
|
2022
Q2 | $51M | Sell |
4,421,528
-43,520
| -1% | -$513K | 0.05% | 377 |
|
|
2022
Q1 | $56.2M | Sell |
4,465,048
-161,535
| -3% | -$1.85M | 0.05% | 403 |
|
|
2021
Q4 | $53.9M | Sell |
4,626,583
-24,308
| -0.5% | -$298K | 0.03% | 603 |
|
|
2021
Q3 | $60.7M | Buy |
4,650,891
+594,844
| +15% | +$7.69M | 0.03% | 569 |
|
|
2021
Q2 | $52.2M | Buy |
4,056,047
+348,217
| +9% | +$3.99M | 0.03% | 661 |
|
|
2021
Q1 | $41.5M | Sell |
3,707,830
-123,521
| -3% | -$1.3M | 0.02% | 787 |
|
|
2020
Q4 | $43.6M | Buy |
3,831,351
+172,393
| +5% | +$1.89M | 0.02% | 776 |
|
|
2020
Q3 | $32.9M | Sell |
3,658,958
-42,731
| -1% | -$425K | 0.02% | 788 |
|
|
2020
Q2 | $38.2M | Buy |
3,701,689
+275,931
| +8% | +$2.82M | 0.03% | 651 |
|
|
2020
Q1 | $34.6M | Buy |
3,425,758
+362,615
| +12% | +$4.26M | 0.03% | 568 |
|
|
2019
Q4 | $40.8M | Sell |
3,063,143
-243,779
| -7% | -$2.69M | 0.03% | 656 |
|
|
2019
Q3 | $28.4M | Buy |
3,306,922
+1,385,005
| +72% | +$13.5M | 0.02% | 720 |
|
|
2019
Q2 | $21M | Buy |
1,921,917
+14,857
| +0.8% | +$166K | 0.02% | 901 |
|
|
2019
Q1 | $21.6M | Buy |
1,907,060
+7,644
| +0.4% | +$85.4K | 0.02% | 821 |
|
|
2018
Q4 | $16.5M | Buy |
1,899,416
+253,291
| +15% | +$2.91M | 0.02% | 892 |
|
|
2018
Q3 | $25.4M | Buy |
1,646,125
+76,552
| +5% | +$1.21M | 0.02% | 747 |
|
|
2018
Q2 | $25.1M | Sell |
1,569,573
-278,038
| -15% | -$4.11M | 0.02% | 714 |
|
|
2018
Q1 | $23.9M | Sell |
1,847,611
-27,307
| -1% | -$340K | 0.02% | 763 |
|
|
2017
Q4 | $23.5M | Sell |
1,874,918
-54
| -0% | -$705 | 0.02% | 801 |
|
|
2017
Q3 | $24.8M | Buy |
1,874,972
+270,742
| +17% | +$3.73M | 0.02% | 712 |
|
|
2017
Q2 | $25.4M | Sell |
1,604,230
-141,939
| -8% | -$2.06M | 0.02% | 689 |
|
|
2017
Q1 | $24.9M | Sell |
1,746,169
-114,594
| -6% | -$1.57M | 0.02% | 715 |
|
|
2016
Q4 | $23.8M | Buy |
1,860,763
+92,732
| +5% | +$1.17M | 0.02% | 719 |
|
|
2016
Q3 | $23.5M | Sell |
1,768,031
-125,494
| -7% | -$1.47M | 0.02% | 738 |
|
|
2016
Q2 | $20.7M | Buy |
1,893,525
+5,589
| +0.3% | +$54.6K | 0.02% | 749 |
|
|
2016
Q1 | $17.3M | Buy |
1,887,936
+143,048
| +8% | +$1.18M | 0.02% | 788 |
|
|
2015
Q4 | $16.9M | Buy |
1,744,888
+26,347
| +2% | +$255K | 0.02% | 867 |
|
|
2015
Q3 | $15M | Sell |
1,718,541
-7,478
| -0.4% | -$69.8K | 0.02% | 900 |
|
|
2015
Q2 | $17.4M | Buy |
1,726,019
+1,592,040
| +1,188% | +$18.5M | 0.02% | 911 |
|
|
2015
Q1 | $1.79M | Sell |
133,979
-5,103
| -4% | -$67K | ﹤0.01% | 2485 |
|
|
2014
Q4 | $1.78M | Buy |
139,082
+59,271
| +74% | +$678K | ﹤0.01% | 2638 |
|
|
2014
Q3 | $866K | Sell |
79,811
-704,880
| -90% | -$8.07M | ﹤0.01% | 3177 |
|
|
2014
Q2 | $10.1M | Buy |
784,691
+651,150
| +488% | +$7.08M | 0.01% | 1396 |
|
|
2014
Q1 | $1.38M | Sell |
133,541
-19,340
| -13% | -$217K | ﹤0.01% | 2828 |
|
|
2013
Q4 | $1.49M | Buy |
152,881
+99,576
| +187% | +$894K | ﹤0.01% | 2937 |
|
|
2013
Q3 | $529K | Sell |
53,305
-74,631
| -58% | -$732K | ﹤0.01% | 3466 |
|
|
2013
Q2 | $1.06M | Buy |
+127,936
| New | +$1.55M | ﹤0.01% | 2743 |
|
Other funds holding IRWD
SCM
AC
B
Credit Suisse's IRWD Position: Q1 2024 in Review
Credit Suisse reduced its Ironwood Pharmaceuticals (IRWD) stake by 96% in Q1 2024, selling an estimated $65.7M and leaving 197,789 shares worth $1.72M. The position accounts for ﹤0.01% of the portfolio, ranked #1959.
Credit Suisse first reported a position in IRWD in Q2 2013 and has held it in 44 quarters since. The position peaked at $64.4M in Q4 2022. 261 funds tracked by Wall St. Rank hold IRWD as of Q1 2024.
- Credit Suisse held 197,789 shares of Ironwood Pharmaceuticals worth $1.72M as of Q1 2024.
- Credit Suisse sold 5,414,324 Ironwood Pharmaceuticals shares in Q1 2024, an estimated $65.7M.
- Ironwood Pharmaceuticals made up ﹤0.01% of Credit Suisse's portfolio in Q1 2024, its #1959 holding.
- Credit Suisse first reported a position in Ironwood Pharmaceuticals in Q2 2013 and has held it in 44 quarters since.
- Credit Suisse's Ironwood Pharmaceuticals position peaked at $64.4M in Q4 2022.
- 261 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q1 2024.
Based on Credit Suisse's 13F filing for Q1 2024, filed 10 May 2024.